Agreement between maternal report and medical records on use of medications during early pregnancy in New York

被引:5
|
作者
Howley, Meredith M. [1 ]
Fisher, Sarah C. [1 ]
Fuentes, Margueritta A. [1 ]
Werler, Martha M. [2 ]
Tracy, Melissa [3 ]
Browne, Marilyn L. [1 ,3 ]
机构
[1] New York State Dept Hlth, Birth Defects Registry, Albany, NY 12208 USA
[2] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA
[3] Univ Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Rensselaer, NY USA
来源
BIRTH DEFECTS RESEARCH | 2023年 / 115卷 / 04期
关键词
agreement; exposure misclassification; kappa; pregnancy; prescription medications; self-report; validity; RECALL; QUESTIONNAIRE; VALIDATION; EXPOSURE; WOMEN;
D O I
10.1002/bdr2.2151
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Studies evaluating associations between medication use in preg-nancy and birth outcomes rely on various sources of exposure information. We sought to assess agreement between self-reported use of medications during early pregnancy and medication information in prenatal medical records to understand the reliability of each of these information sources.Methods: We compared self-reported prescription medication use in early pregnancy to medical records from 184 New York women with deliveries in 2018 who participated in the Birth Defects Study To Evaluate Pregnancy expo-sureS. We assessed medications used chronically and episodically, and medica-tions within 12 therapeutic groups. We calculated agreement using kappa (x) coefficients, sensitivity, and specificity. We assessed differences by case/control status, maternal age, education, time to interview, and interview language.Results: Medications used chronically showed substantial agreement between self-report and medical records (x = 0.75, 0.61-0.88), with agreement for therapeu-tic groups used chronically ranging from x = 0.61 for antidiabetics to x = 1.00 for antihypertensives. Prescription medications used episodically showed worse agree-ment (x = 0.40, 0.25-0.54), with the lowest agreement for opioid analgesics (x = 0.20) and anti-infectives (x = 0.33). Agreement did not differ by the character-istics examined, although we observed potential differences by interview language.Conclusions: Among our sample, we observed good agreement between self-report and medical records for medications used chronically and substantially less agreement for medications used episodically. Differences by source may be due to poor recall in self-reports, non-adherence with prescribed medications and lack of complete prescription information within medical records. Limita-tions should be considered when assessing prescription medication exposures during early pregnancy in epidemiologic studies.
引用
收藏
页码:498 / 509
页数:12
相关论文
共 50 条
  • [1] Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis
    Palmsten, Kristin
    Hulugalle, Avanthi
    Bandoli, Gretchen
    Kuo, Grace M.
    Ansari, Shayda
    Xu, Ronghui
    Chambers, Christina D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 444 - 444
  • [2] Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma
    Palmsten, Kristin
    Hulugalle, Avanthi
    Bandoli, Gretchen
    Kuo, Grace M.
    Ansari, Shayda
    Xu, Ronghui
    Chambers, Christina D.
    [J]. PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2018, 32 (01) : 68 - 77
  • [3] MATERNAL RECALL AND MEDICAL RECORDS - AN EXAMINATION OF EVENTS DURING PREGNANCY, CHILDBIRTH, AND EARLY INFANCY
    GITHENS, PB
    GLASS, CA
    SLOAN, FA
    ENTMAN, SS
    [J]. BIRTH-ISSUES IN PERINATAL CARE, 1993, 20 (03): : 136 - 141
  • [4] Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects
    Anderson, Kayla N.
    Lind, Jennifer N.
    Simeone, Regina M.
    Bobo, William V.
    Mitchell, Allen A.
    Riehle-Colarusso, Tiffany
    Polen, Kara N.
    Reefhuis, Jennita
    [J]. JAMA PSYCHIATRY, 2020, 77 (12) : 1246 - 1255
  • [5] Maternal early pregnancy use of specific antidepressant medications and risk for birth defects
    Anderson, Kayla N.
    Lind, Jennifer N.
    Simeone, Regina
    Bobo, William V.
    Riehle-Colarusso, Tiffany
    Polen, Kara N.
    Reefhuis, Jennita
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 367 - 368
  • [6] Maternal use of thyroid hormone replacement therapy before, during, and after pregnancy: agreement between self-report and prescription records and group-based trajectory modeling of prescription patterns
    Frank, Anna S.
    Lupattelli, Angela
    Matteson, David S.
    Nordeng, Hedvig
    [J]. CLINICAL EPIDEMIOLOGY, 2018, 10 : 1801 - 1816
  • [7] Detecting pregnancy use of non-hormonal category X medications in electronic medical records
    Strom, Brian L.
    Schinnar, Rita
    Jones, Joshua
    Bilker, Warren B.
    Weiner, Mark G.
    Hennessy, Sean
    Leonard, Charles E.
    Cronholm, Peter F.
    Pifer, Eric
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2011, 18 : I81 - I86
  • [8] Maternal infections and medications in pregnancy: how does self-report compare to medical records in childhood cancer case-control studies?
    Bonaventure, Audrey
    Kane, Eleanor
    Simpson, Jill
    Roman, Eve
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2023, 52 (04) : 1187 - 1196
  • [9] Use of Antihistamine Medications during Early Pregnancy and Isolated Major Malformations
    Gilboa, Suzanne M.
    Strickland, Matthew J.
    Olshan, Andrew F.
    Werler, Martha M.
    Correa, Adolfo
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2009, 85 (02) : 137 - 150
  • [10] Agreement Between Postnatal Meconium Drug Screen and Maternal Urine Drug Screen for Drug Use During Pregnancy
    Debbink, Michelle
    Smith, Shannon
    Langen, Elizabeth
    [J]. OBSTETRICS AND GYNECOLOGY, 2017, 129 : 34S - 34S